ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HWKN Hawkins Inc

106.90
0.00 (0.00%)
Pre Market
Last Updated: 08:05:16
Delayed by 15 minutes
Share Name Share Symbol Market Type
Hawkins Inc NASDAQ:HWKN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 106.90 108.00 141.18 0 08:05:16

Hawkins, Inc. Reports Second Quarter Fiscal 2025 Results

30/10/2024 8:10pm

GlobeNewswire Inc.


Hawkins (NASDAQ:HWKN)
Intraday Stock Chart


Friday 1 November 2024

Click Here for more Hawkins Charts.

Hawkins, Inc. (Nasdaq: HWKN) today announced results for the six months ended September 29, 2024, its second quarter of fiscal 2025.

Second Quarter Fiscal Year 2025 Highlights:

  • Record second quarter results for revenue, gross profit, operating income, net income, diluted earnings per share (“EPS”) and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure.
  • Overall revenue growth of 4%, once again driven by the Water Treatment segment growth of 23% over the same period of the prior year.
  • Gross profit increase of 12% over the same period of the prior year, with Water Treatment segment gross profit growth of 22%.
  • Second quarter operating income of $33.7 million, our 26th consecutive quarter of year-over-year operating income increase.
  • Diluted EPS of $1.16, an increase of $0.06, or 5%, compared to the same period of the prior year.
  • Adjusted EBITDA, a non-GAAP measure, of $46.3 million, a 12% increase over the same period of the prior year. Trailing 12-month adjusted EBITDA exceeded $157 million.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Our record performance in the second quarter was once again driven by our Water Treatment business, as we continued to gain efficiencies within our recent acquisitions and made progress towards future acquisition targets. Within the quarter we saw strong revenue growth of 23% in our Water Treatment business driven by our recent acquisitions, with organic volume flat due to unfavorable weather conditions in several regions. Revenue in our Industrial segment declined year over year due primarily to reduced selling prices driven by lower commodity costs, with volumes up slightly. Health and Nutrition revenues declined due to lower sales of our manufactured products and overall softness in the market. Overall, we saw 4% revenue growth with gross profit increasing 12%, overcoming the $3.2 million LIFO benefit we saw in the second quarter of fiscal 2024.”  

Mr. Hawkins, continued, “Our balance sheet continues to be strong, as we paid down $30 million of debt within the quarter, resulting in our leverage ratio being 0.65x trailing 12-month proforma adjusted EBITDA at the end of the quarter. Looking to the third quarter, we expect continued growth within our Water Treatment segment and for our Health and Nutrition segment to resume growth. We expect to see our Industrial segment continue to perform similar to the first half of fiscal 2025.”

Second Quarter Financial Highlights:

NET INCOME

For the second quarter of fiscal 2025, the Company reported net income of $24.1 million, or $1.16 per diluted share, compared to net income for the second quarter of fiscal 2024 of $23.2 million, or $1.10 per diluted share.

REVENUE

Sales were $247.0 million for the second quarter of fiscal 2025, an increase of $10.5 million, or 4%, from sales of $236.5 million in the same period a year ago. Increased sales in our Water Treatment segment more than offset sales softness in our Industrial and Health and Nutrition segments. Water Treatment segment sales increased $23.6 million, or 23%, to $124.5 million for the current quarter, from $100.9 million in the same period a year ago. Water Treatment sales increased as a result of added sales from our acquired businesses. Industrial segment sales decreased $8.6 million, or 9%, to $89.9 million for the current quarter, from $98.5 million in the same period a year ago. Although overall volumes increased slightly year over year, sales decreased as a result of lower selling prices on certain products, driven by lower raw material costs and competitive pricing actions. Health and Nutrition segment sales decreased $4.5 million, or 12%, to $32.6 million for the current quarter, from $37.1 million in the same period a year ago. Health and Nutrition sales decreased due to lower sales of our manufactured products driven by reduced volumes and selling prices due to decreased demand for certain of our products.

GROSS PROFIT

Gross profit increased $6.3 million, or 12%, to $60.2 million, or 24% of sales, for the current quarter, from $53.9 million, or 23% of sales, in the same period a year ago. During the current quarter, the LIFO reserve was unchanged, having no impact on gross profit. In the same quarter a year ago, the LIFO reserve decreased, and gross profit increased, by $3.2 million. Gross profit for the Water Treatment segment increased $6.3 million, or 22%, to $35.6 million, or 29% of sales, for the current quarter, from $29.3 million, or 29% of sales, in the same period a year ago. Water Treatment segment gross profit increased as a result of increased sales from our acquired businesses. Gross profit for the Industrial segment increased $0.5 million, or 3%, to $18.3 million, or 20% of sales, for the current quarter, from $17.8 million, or 18% of sales, in the same period a year ago. Industrial segment gross profit increased as a result of increased volumes of certain products and product mix changes. Gross profit for our Health and Nutrition segment decreased $0.3 million, or 4%, to $6.4 million, or 20% of sales, for the current quarter, from $6.7 million, or 18% of sales, in the same period a year ago. Health and Nutrition segment gross profit decreased as a result of the decrease in sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative expenses increased $5.6 million, or 27%, to $26.5 million, or 11% of sales, for the current quarter, from $20.9 million, or 9% of sales, in the same period a year ago. Expenses increased primarily due to $3.8 million in added costs from the acquired businesses in our Water Treatment segment, including amortization of intangibles of $1.5 million. In addition, a year-over-year increase of $1.0 million in compensation expense related to our non-qualified deferred compensation plan increased SG&A expenses, with the offset in other income.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended September 29, 2024 was $46.3 million, an increase of $4.8 million, or 12%, from $41.5 million in the same period a year ago.

INCOME TAXES

Our effective income tax rate was 27% for both the current quarter and for the same period a year ago. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.

BALANCE SHEET

At the end of the second quarter, our working capital was $18 million higher than the end of fiscal 2024 due primarily to increased inventory and lower liabilities due to the payment of certain year-end accruals in the first quarter. During the quarter, we paid down $30 million on our line of credit. Year-to-date net borrowings of $5.0 million and $59.2 million of operating cash flow was used to fund $25.4 million of acquisition spending for the acquisitions of Intercoastal Trading, Inc. and Wofford Water Service, Inc., capital spending of $21.3 million, stock repurchases of $9.1 million and dividend payments of $7.1 million. Our total debt outstanding at the end of the second quarter was $104.0 million and our leverage ratio was 0.65x our trailing 12-month proforma adjusted EBITDA, as compared to 0.66x of trailing twelve-month adjusted EBITDA at the end of fiscal 2024.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 61 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $919 million of revenue in fiscal 2024 and has approximately 1,000 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.

Adjusted EBITDAThree Months Ended Six months ended Trailing 12-months ended
(In thousands)September 29,2024 October 1,2023 September 29,2024 October 1,2023 September 29,2024
Net Income (GAAP)$24,118 $23,216 $52,997 $46,646 $81,714
Interest expense, net 1,427  717  2,690  1,865  5,107
Income tax expense 8,873  8,769  18,681  17,015  27,447
Amortization of intangibles 3,196  1,724  5,998  3,394  11,143
Depreciation expense 6,731  5,675  13,258  11,112  25,410
Non-cash compensation expense 1,832  1,260  3,299  2,219  5,960
Non-recurring acquisition expenses 94  122  282  122  1,077
Adjusted EBITDA$46,271 $41,483 $97,205 $82,373 $157,858

HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
 
  Three Months Ended Six Months Ended
  September 29,2024 October 01,2023 September 29,2024 October 01,2023
Sales $247,029  $236,526  $502,908  $487,646 
Cost of sales  (186,807)  (182,640)  (378,031)  (381,769)
Gross profit  60,222   53,886   124,877   105,877 
Selling, general and administrative expenses  (26,477)  (20,895)  (51,341)  (40,399)
Operating income  33,745   32,991   73,536   65,478 
Interest expense, net  (1,427)  (717)  (2,690)  (1,865)
Other income (expense)  673   (289)  832   48 
Income before income taxes  32,991   31,985   71,678   63,661 
Income tax expense  (8,873)  (8,769)  (18,681)  (17,015)
Net income $24,118  $23,216  $52,997  $46,646 
         
Weighted average number of shares outstanding - basic  20,757,397   20,903,690   20,786,938   20,905,707 
Weighted average number of shares outstanding - diluted  20,860,418   21,026,428   20,898,641   21,034,153 
Basic earnings per share $1.16  $1.11  $2.55  $2.23 
Diluted earnings per share $1.16  $1.10  $2.54  $2.22 
Cash dividends declared per common share $0.18  $0.16  $0.34  $0.31 

HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
 
  September 29,2024 March 31,2024
ASSETS    
CURRENT ASSETS:    
Cash and cash equivalents $7,526 $7,153
Trade accounts receivables, net  115,221  114,477
Inventories  81,565  74,600
Prepaid expenses and other current assets  5,563  6,596
Total current assets  209,875  202,826
PROPERTY, PLANT, AND EQUIPMENT:  402,104  386,648
Less accumulated depreciation  184,642  177,774
Net property, plant, and equipment  217,462  208,874
OTHER ASSETS:    
Right-of-use assets  12,047  11,713
Goodwill  111,566  103,399
Intangible assets, net of accumulated amortization  123,886  116,626
Deferred compensation plan asset  11,698  9,584
Other  3,163  4,912
Total other assets  262,360  246,234
Total assets $689,697 $657,934
LIABILITIES AND SHAREHOLDERS’ EQUITY    
CURRENT LIABILITIES:    
Accounts payable — trade $50,956 $56,387
Accrued payroll and employee benefits  12,701  19,532
Income tax payable  2,284  1,943
Current portion of long-term debt  9,913  9,913
Environmental remediation  7,700  7,700
Other current liabilities  8,787  7,832
Total current liabilities  92,341  103,307
LONG-TERM DEBT, LESS CURRENT PORTION  93,862  88,818
LONG-TERM LEASE LIABILITY  9,687  9,530
PENSION WITHDRAWAL LIABILITY  3,348  3,538
DEFERRED INCOME TAXES  21,875  22,406
DEFERRED COMPENSATION LIABILITY  13,057  11,764
EARNOUT LIABILITY  11,919  11,235
OTHER LONG-TERM LIABILITIES  236  1,310
Total liabilities  246,325  251,908
COMMITMENTS AND CONTINGENCIES    
SHAREHOLDERS’ EQUITY:    
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,766,764 and 20,790,261 shares issued and outstanding as of September 29, 2024 and March 31, 2024, respectively  208  208
Additional paid-in capital  31,060  38,154
Retained earnings  410,425  364,549
Accumulated other comprehensive income  1,679  3,115
Total shareholders’ equity  443,372  406,026
Total liabilities and shareholders’ equity $689,697 $657,934

HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
  Six Months Ended
  September 29,2024 October 1,2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $52,997  $46,646 
Reconciliation to cash flows:    
Depreciation and amortization  19,256   14,506 
Change in fair value of earnout liability  684    
Operating leases  1,607   1,115 
Gain on deferred compensation assets  (833)  (48)
Stock compensation expense  3,299   2,219 
Other  (32)  (34)
Changes in operating accounts providing (using) cash:    
Trade receivables  616   4,909 
Inventories  (6,403)  20,752 
Accounts payable  (4,218)  6,421 
Accrued liabilities  (7,285)  (7,149)
Lease liabilities  (1,624)  (1,127)
Income taxes  341   990 
Other  811   3,430 
Net cash provided by operating activities  59,216   92,630 
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property, plant, and equipment  (21,286)  (16,922)
Acquisitions  (25,400)  (3,355)
Other  357   335 
Net cash used in investing activities  (46,329)  (19,942)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends declared and paid  (7,121)  (6,535)
New shares issued  1,297   1,147 
Payroll taxes paid in exchange for shares withheld  (2,541)  (2,140)
Shares repurchased  (9,149)  (9,752)
Payments on revolving loan  (40,000)  (52,000)
Proceeds from revolving loan borrowings  45,000    
Net cash used in financing activities  (12,514)  (69,280)
NET INCREASE IN CASH AND CASH EQUIVALENTS  373   3,408 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD  7,153   7,566 
CASH AND CASH EQUIVALENTS, END OF PERIOD $7,526  $10,974 
     
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Cash paid for income taxes $18,340  $16,025 
Cash paid for interest $2,923  $2,002 
Noncash investing activities - capital expenditures in accounts payable $1,094  $2,970 

HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)
 
 WaterTreatment Industrial Health and Nutrition Total
Three months ended September 29, 2024:       
Sales$124,528 $89,936 $32,565 $247,029
Gross profit 35,590  18,268  6,364  60,222
Selling, general, and administrative expenses 15,512  6,952  4,013  26,477
Operating income 20,078  11,316  2,351  33,745
Three months ended October 1, 2023:       
Sales$100,925 $98,535 $37,066 $236,526
Gross profit 29,308  17,844  6,734  53,886
Selling, general, and administrative expenses 10,145  6,806  3,944  20,895
Operating income 19,163  11,038  2,790  32,991
Six months ended September 29, 2024:       
Sales$241,704 $193,138 $68,066 $502,908
Gross profit 70,545  40,144  14,188  124,877
Selling, general and administrative expenses 29,678  13,591  8,072  51,341
Operating income 40,867  26,553  6,116  73,536
Six months ended October 1, 2023:       
Sales$194,576 $219,408 $73,662 $487,646
Gross profit 55,716  37,150  13,011  105,877
Selling, general and administrative expenses 19,271  13,381  7,747  40,399
Operating income 36,445  23,769  5,264  65,478
            

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts: Jeffrey P. Oldenkamp
  Executive Vice President and Chief Financial Officer
  612/331-6910
  ir@HawkinsInc.com

1 Year Hawkins Chart

1 Year Hawkins Chart

1 Month Hawkins Chart

1 Month Hawkins Chart